Understanding determinants of type 1 diabetes and kidney disease

Project opportunity

This Earmarked Scholarship project is aligned with a recently awarded Category 1 research grant. It offers you the opportunity to work with leading researchers and contribute to large projects of national significance.

Mater Research Institute-UQ (MRI-UQ) is a world class institute committed to academic research and its translation into clinical care for the benefit of all. MRI-UQ is an alliance between Mater Research and UQ, providing strategic and operational benefits to both parties. Mater Research brings to the alliance considerable clinical collaboration opportunites and UQ brings all its expertise as a research, education and teaching institution. MRI-UQ has more than 300 research staff, post graduate students and clinical researchers. There are currently ~100 students undertaking a PhD, MPhil or Honours program.

The project supervisor is Professor Josephine Forbes, an internationally-recognised expert in diabetes and its complications. Her team’s research program is interested in the discovery of medicines to prevent and treat diabetes and the specific complication of kidney disease. She has two major programs which have a significant proportion of clinical studies but can also include basic and commercial aspects. The first examines the role of mitochondria, the cellular power stations and consequential metabolic defects in precipitating and progressing kidney disease. The second program is understanding the role of the receptor for advanced glycation end products in the development of type 1 diabetes and includes both T cell immunology, clinical cohort studies and the study of the pancreatic islets.

Scholarship value

As a scholarship recipient, you'll receive: 

  • living stipend of $29,863 per annum tax free (2023 rate), indexed annually
  • tuition fees covered
  • single Overseas Student Health Cover (OSHC)

Supervisor

Professor Josephine Forbes

Faculty of Medicine

Email: josephine.forbes@mater.uq.edu.au

Preferred educational background

Your application will be assessed on a competitive basis.

We take into account your

  • previous academic record
  • publication record
  • honours and awards
  • employment history.

A working knowledge of immunology, physiology, biochemistry, or molecular biology would be of benefit to someone working on this project.

Applicants must have the ability to develop technical laboratory skills including in vitro and in vivo techniques, and skills in research methodology, data analysis, and scientific writing.

Applicants will have the desire, motivation and ethics to be involved in research studies that extend to both clinical and laboratory research.

Applicants must have an excellent communication skill set including writing ability, and the capacity to work effectively within a multidisciplinary and international research team.

The applicant will demonstrate academic achievement in the field(s) of  medicine, Immunology, pathology and the potential for scholastic success.

A background or knowledge of diabetes is highly desirable.

Latest commencement date

If you are the successful candidate, you must commence by Research Quarter 1, 2025. You should apply at least 3 months prior to the research quarter commencement date.

If you are an international applicant, you may need to apply much earlier for visa requirements.

How to apply

You apply for this project as part of your PhD program application.

View application process